Safety in numbers: risankizumab for moderate-to-severe psoriasis

S Mirali, K Fabusiwa,E Linos

BRITISH JOURNAL OF DERMATOLOGY(2022)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要